ID: ALA3649413

Max Phase: Preclinical

Molecular Formula: C31H35Cl2N3O7S

Molecular Weight: 664.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](NC(=O)[C@@H]1C[C@@H](S(=O)(=O)c2ccccc2Cl)CN1C(=O)C1(c2ccc(Cl)cc2)CC1)C(=O)C(=O)NC1CCOCC1

Standard InChI:  InChI=1S/C31H35Cl2N3O7S/c1-2-24(27(37)29(39)34-21-11-15-43-16-12-21)35-28(38)25-17-22(44(41,42)26-6-4-3-5-23(26)33)18-36(25)30(40)31(13-14-31)19-7-9-20(32)10-8-19/h3-10,21-22,24-25H,2,11-18H2,1H3,(H,34,39)(H,35,38)/t22-,24+,25+/m1/s1

Standard InChI Key:  YRDWNESAGCXMTG-VJTSUQJLSA-N

Associated Targets(Human)

CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 664.61Molecular Weight (Monoisotopic): 663.1573AlogP: 3.23#Rotatable Bonds: 10
Polar Surface Area: 138.95Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.66CX Basic pKa: CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.37Np Likeness Score: -0.85

References

1.  (2014)  Pyrrolidine derivatives, 

Source

Source(1):